The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...

Cigna (CI) and UnitedHealth (UNH) significantly marked up prices for specialty generic drugs over a six-year period.

CVS Pharmacy Inc. is being sued by the U.S. Department ... Download USA TODAY's app to get to the heart of news David Lynch, legendary director of 'Twin Peaks' and 'Blue Velvet,' dead at 78 ...

Three major drug middlemenneedlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

A new Essex mum says giving birth caused her heart to fail and left her needing a new one - just three months after having ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

A recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...